Skip to main content
. 2023 Jan 13;13:1091103. doi: 10.3389/fimmu.2022.1091103

Figure 3.

Figure 3

Comparison of the methylation of AHNAK and STAP1 among different types of liver disease in the Gene Expression Omnibus datasets. (A) Comparisons in STAP1 methylation among the different types of liver cirrhosis and hepatocellular carcinoma (HCC) patients (GSE60753 data). (B) Comparisons in STAP1 methylation among the chronic hepatitis B (CHB), liver cirrhosis, and HCC patients and benign liver lesions (GSE112679 data). (C) Comparisons in AHNAK methylation among the CHB, liver cirrhosis, and HCC patients and benign liver lesions (GSE112679 data). *P < 0.05, **P < 0.01, ***p < = 0.001, ****p < = 0.0001.